[1]Alvarez F, Berg PA, Bianchi FB, et al.International AutoimmuneHepatitis Group Report:review of criteria for diagnosis of autoim-mune Hepatitis[J].J Hepatol, 1999, 31 (5) ∶929-938.
|
[2]Heathcote EJ.Management of primary biliary cirrhosis.The Ameri-can Association for the Study of Liver Diseases practiceguidelines[J].Hepatology, 2000, 31 (4) ∶1005-1013.
|
[3]Chazouilleres O, Wendum D, Serfaty L, et al.Primary biliary cir-rhosis autoimmune hepatitis overlap syndrome:clinical features andresponse to therapy[J].Hepatoloyg, 1998, 28 (2) ∶296-301.
|
[4] 中华医学会.病毒性肝炎防治方案[J].中华肝脏病杂志, 2000, 8 (6) ∶324-329.
|
[5]周毅, 杨旭, 刘桃成, 等.自身免疫性肝炎重叠综合症的临床与诊断的初步探讨[J].湖南师范大学学报, 2006, 3 (3) ∶27-30.
|
[6]贾继东.自身免疫性肝病的基本概念和诊断思路[J].中华肝脏病杂志, 2005, 13 (1) ∶54-55.
|
[7]黄加权, 郑志想, 黄铁军, 等.慢性肝病自身抗体的检测及其与自身免疫性肝病的相关性[J].华中科技大学学报, 2006, 35 (2) ∶195-198.
|
[8]邱德凯, 马雄.自身免疫性肝病的诊断和治疗[J].中华肝病杂志, 2005, 13 (1) ∶50-51.
|
[9]Costenbader KH, Karlson EW.Cigarette smoking and autoimmunedisease:what can we learn from epidemiology?[J].Lupus, 2006, 15 (11) ∶737-745.
|
[10]黄从云.肝硬化与肝脏免疫系统[J].国外医学外国学分册, 2004, 31 (2) ∶104-105.
|
[11]王江滨.淋巴肝的新概念及自身免疫性肝病的免疫损伤机制[J].中国免疫学杂志, 2003, 19 (11) ∶799-803.
|
[12]Watanabe S.Therapeutic effects of stronger neo-minophagene atdifferent does on chronic hepatitis and liver cirrhosis[J].HepatolRes, 2001, 19 (1) ∶41-51.
|
[13]Ishibashi H, Komori A, Shimoda S, et al.Guidelines for therapy ofautoimmune liver disease[J].Semin Liver Dis, 2007, 27 (2) ∶214-226.
|
[14]Czaja AJ.Autoimmune liver disease[J].Curr Opin Gastroenterol, 2007, 23 (3) ∶255-262.
|